Aspira Women's Health Inc. DEF 14A Filing

Ticker: AWHL · Form: DEF 14A · Filed: 2025-04-11T00:00:00.000Z

Sentiment: neutral

Topics: executive-compensation, board-of-directors, sec-filing, corporate-governance

Related Tickers: AWH

TL;DR

Aspira Women's Health Inc. filed its DEF 14A, showing exec comp for 2024. Board members like Sandra Milligan and Nicole Sandford are listed.

AI Summary

Aspira Women's Health Inc. filed a DEF 14A on April 11, 2025, detailing executive compensation and board member information for the fiscal year ending December 31, 2024. The filing includes compensation details for Sandra Milligan and Nicole Sandford, among others, and reports on equity awards granted during the 2024 fiscal year.

Why It Matters

This filing provides transparency into the compensation packages of Aspira Women's Health Inc.'s top executives and board members, which can influence investor decisions and corporate governance evaluations.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of executive compensation and board information, not indicating any immediate financial distress or significant operational changes.

Key Players & Entities

Aspira Women's Health Inc. (company) — Filer of the DEF 14A
Sandra Milligan (person) — Board Member and recipient of equity awards
Nicole Sandford (person) — Board Member
2024-12-31 (date) — Fiscal year end for reported compensation
20250411 (date) — Filing date of the DEF 14A

FAQ

What is the primary purpose of this DEF 14A filing for Aspira Women's Health Inc.?

The primary purpose is to disclose information regarding executive compensation, board member details, and other corporate governance matters for the fiscal year ending December 31, 2024.

Who are the key individuals whose compensation is detailed in this filing?

Key individuals include board members such as Sandra Milligan and Nicole Sandford, along with other executive and non-executive board members.

What period does the compensation information in this filing cover?

The compensation information primarily covers the fiscal year ending December 31, 2024, with some comparative data from previous years.

What type of awards are mentioned in relation to Sandra Milligan?

Equity awards are mentioned in relation to Sandra Milligan, specifically as a reported value of equity awards for the 2024 fiscal year.

When was this DEF 14A filing submitted to the SEC?

This DEF 14A filing was submitted to the SEC on April 11, 2025.

From the Filing

0001641172-25-003902.txt : 20250411 0001641172-25-003902.hdr.sgml : 20250411 20250411172924 ACCESSION NUMBER: 0001641172-25-003902 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250411 DATE AS OF CHANGE: 20250411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences EIN: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 25833718 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 DEF 14A 1 formdef14a.htm false 0000926617 DEF 14A 0000926617 2024-01-01 2024-12-31 0000926617 AWH:SandraMilliganMember 2024-01-01 2024-12-31 0000926617 AWH:NicoleSandfordMember 2024-01-01 2024-12-31 0000926617 ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0000926617 AWH:SandraMilliganMember 2023-01-01 2023-12-31 0000926617 AWH:NicoleSandfordMember 2023-01-01 2023-12-31 0000926617 ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0000926617 2023-01-01 2023-12-31 0000926617 AWH:SandraMilliganMember 2022-01-01 2022-12-31 0000926617 AWH:NicoleSandfordMember 2022-01-01 2022-12-31 0000926617 ecd:NonPeoNeoMember 2022-01-01 2022-12-31 0000926617 2022-01-01 2022-12-31 0000926617 AWH:SandraMilliganMember AWH:ReportedValueOfEquityAwardsMember 2024-01-01 2024-12-31 0000926617 AWH:SandraMilliganMember AWH:EquityAwardAdjustmentsMember 2024-01-01 2024-12-31 0000926617 AWH:SandraMilliganMember AWH:YearEndFairValueOfEquityAwardsMember 2024-01-01 2024-12-31 0000926617 AWH:SandraMilliganMember AWH:ChangeInFairValueFromTheEndOfThePriorYearToTheEndOfTheApplicableYearOfOutstandingAndUnvestedEquityAwardsMember 2024-01-01 2024-12-31 0000926617 AWH:SandraMilliganMember AWH:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember 2024-01-01 2024-12-31 0000926617 AWH:SandraMilliganMember AWH:ChangeInFairValueOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember 2024-01-01 2024-12-31 0000926617 AWH:NicoleSandfordMember AWH:ReportedValueOfEquityAwardsMember 2024-01-01 2024-12-31 0000926617 AWH:NicoleSandfordMember AWH:EquityAwardAdjustmentsMember 2024-01-01 2024-12-31 0000926617 AWH:NicoleSandfordMember AWH:ReportedValueOfEquityAwardsMember 2023-01-01 2023-12-31 0000926617 AWH:NicoleSandfordMember AWH:EquityAwardAdjustmentsMember 2023-01-01 2023-12-31 0000926617 AWH:NicoleSandfordMember AWH:ReportedValueOfEquityAwardsMember 2022-01-01 2022-12-31 0000926617 AWH:NicoleSandfordMember AWH:EquityAwardAdjustmentsMember 2022-01-01 2022-12-31 0000926617 AWH:NicoleSandfordMember AWH:YearEndFairValueOfEquityAwardsMember 2024-01-01 2024-12-31 0000926617 AWH:NicoleSandfordMember AWH:ChangeInFairValueFromTheEndOfThePriorYearToTheEndOfTheApplicableYearOfOutstandingAndUnvestedEquityAwardsMember 2024-01-01 2024-12-31 0000926617 AWH:NicoleSandfordMember AWH:ChangeInFairValueOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember 2024-01-01 2024-12-31 0000926617 AWH:NicoleSandfordMember AWH:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember 2024-01-01 2024-12-31 0000926617 AWH:NicoleSandfordMember AWH:YearEndFairValueOfEquityAwardsMember 2023-01-01 2023-12-31 0000926617 AWH:NicoleSandfordMember AWH:ChangeInFairValueFromTheEndOfThePriorYearToTheEndOfTheApplicableYearOfOutstandingAndUnvestedEquityAwardsMember 2023-01-01 2023-12-31 0000926617